
The Global Lung Cancer Coalition (GLCC) has published the findings of our fifth international public attitudes survey, as Lung Cancer Awareness Month begins.
This latest study reveals encouraging improvements in awareness of lung cancer symptoms and reductions in stigma, while highlighting the continued need for action to improve understanding of the disease and support earlier diagnosis.
The 2026 survey was conducted across 32 countries and territories in Europe, North and South America, Asia, Africa and Oceania. It explored public awareness of lung cancer symptoms, attitudes towards people living with lung cancer, and views on national lung cancer screening programmes. The study builds on GLCC research previously undertaken in 2010, 2013, 2017 and 2023.
The findings reinforce a central principle of the GLCC Patient Charter: that everyone living with lung cancer has the right to dignity, respect, quality care, informed decision making, privacy, and freedom from blame and stigma. Public attitudes can have a significant impact on these rights and on the experiences of people affected by the disease.
Encouragingly, awareness of lung cancer symptoms has improved since the previous survey in 2023. However, knowledge remains worryingly low. Nearly one-third of respondents (32.7%) said they could not name a single symptom of lung cancer, although this represents an improvement from 37.5% in 2023.
The survey identified important differences between population groups. Men were more likely than women to report not knowing any symptoms of lung cancer (35.9% versus 30.1%), while awareness was lowest among younger adults aged 18 to 24, more than a third of whom (36.8%) could not identify any symptoms. People who had never smoked were also less likely to recognise symptoms than current or former smokers.
While the findings suggest attitudes towards lung cancer are improving, stigma remains a significant challenge. Nearly four in ten respondents (39.2%) agreed that they had less sympathy for people living with lung cancer than for people with other forms of cancer. Although this figure has fallen from 42.6% in 2023, it demonstrates that misconceptions and blame continue to affect public perceptions of the disease.
Negative attitudes were more common among men, with 45% agreeing they felt less sympathy towards people with lung cancer compared with 34.3% of women. Younger adults were also more likely to hold this view, with 45.5% of those aged 18 to 24 agreeing, compared with 29.3% of people aged 55 and over.
Strong support for screening

In contrast, support for lung cancer screening remains consistently strong. More than eight in ten respondents (84.3%) agreed that their country should have a national lung cancer screening programme to help diagnose the disease earlier, a figure that has remained broadly unchanged since 2023.
Support for screening was high across all demographic groups. Women were slightly more supportive than men (86.1% versus 82.2%), while levels of support exceeded 80% in every age group surveyed. Current and former smokers were also more likely than people who had never smoked to back national screening programmes.
Taken together, the findings highlight both progress and ongoing challenges. Improvements in symptom awareness and reductions in stigma are encouraging, but too many people remain unaware of the signs of lung cancer and negative attitudes towards those living with the disease remain widespread. At the same time, strong public support for screening demonstrates broad recognition of the importance of early diagnosis.
In response to the survey findings, the GLCC is calling on governments and health systems worldwide to increase public awareness of lung cancer symptoms, challenge stigma through evidence-based education initiatives, implement national lung cancer screening programmes where they do not already exist, and ensure equitable access to screening, diagnosis and care for everyone affected by lung cancer.
The survey was conducted online by Censuswide between 17 and 24 March 2026. More than 1,000 adults were surveyed in each participating country and territory, with results weighted by age, gender and region to ensure representative national samples.
